Market Place
Sourcing Support
Flamingo folds Dynacure into its flamboyance in merger deal
02 Mar 2023 //
FIERCE BIOTECH
Flamingo Therapeutics and Dynacure Announce Merger
02 Mar 2023 //
PR NEWSWIRE
Dynacure Axes Investigational Study of CNM Treatment
09 Jul 2022 //
BIOSPACE
FDA grants FTD to Dynacure’s DYN101 in myotubular and centronuclear myopathies
08 Jan 2022 //
PHARMABIZ
Nippon Shinyaku, Dynacure partner to develop & commercialize DYN101 in Japan
11 Nov 2021 //
PHARMABIZ
Dynacure Announces Strategic Collaboration and Option Agreement with Nippon
10 Nov 2021 //
PRNEWSWIRE
Dynacure Announces FDA Acceptance of IND Application for DYN101
09 Jun 2021 //
PRNEWSWIRE
Dynacure Announces Issuance of U.S. Patent for DYN101 for the of Myotubular
26 Jan 2021 //
PRNEWSWIRE
Dynacure Announces Issuance of U.S. Patent for DYN101 for CNM
26 Jan 2021 //
PRNEWSWIRE
Dynacure announces publication of Hierarchical Bayesian modelling
15 Jan 2021 //
PRNEWSWIRE
Dynacure Receives Rare Pediatric from U.S. Food Drug Administration for DYN101
30 Jul 2020 //
PRNEWSWIRE
Dynacure Receives Rare Pediatric Disease Designation from USFDA for DYN101
30 Jul 2020 //
PRNEWSWIRE
Dynacure Announces Presentation at Jefferies Virtual Global Conference
27 May 2020 //
PRNEWSWIRE
Dynacure Announces €50M ($55M) Series C Financing
02 Apr 2020 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.